Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma-Reference-Cited by-同舟云学术

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma

Published:2008-12-17 Issue:1 Volume:115 Page:119-127
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Perez Domingo G.,Suman Vera J.,Fitch Tom R.,Amatruda Thomas,Morton Roscoe F.,Jilani Shamim Z.,Constantinou Costas L.,Egner James R.,Kottschade Lisa A.,Markovic Svetomir N.

Funder

Public Health Service

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23987/fullpdf

Reference35 articles.

1. The vascular endothelial growth factor family and its receptors;Parikh;Hematol Oncol Clin North Am.,2004

2. The biology of VEGF and its receptors;Ferrara;Nat Med.,2003

3. Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications;Srivastava;Microsc Res Tech.,2003

4. Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling;Graells;J Invest Dermatol.,2004

5. Angiogenesis, lymphangiogenesis, and melanoma metastasis;Streit;Oncogene.,2003

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Melanoma Therapies: From Surgery to Immunotherapy;Current Treatment Options in Oncology;2024-07-27

2. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

3. Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?;The Cancer Journal;2024-03

4. Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies;Frontiers in Pharmacology;2023-07-13

5. Managing Metastatic Melanoma in 2022: A Clinical Review;JCO Oncology Practice;2022-05